nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Academic perspectives on dietary supplements use: The need for new guidelines
|
Grollman, Arthur P. |
|
2005 |
117 |
1-2 |
p. 185-192 8 p. |
artikel |
2 |
Agenda item: Questions, panel discussion and summary
|
Kingston, Rick |
|
2005 |
117 |
1-2 |
p. 145-151 7 p. |
artikel |
3 |
A systematic review and inventory of supplement effects on warfarin and other anticoagulants
|
Wittkowsky, Ann K. |
|
2005 |
117 |
1-2 |
p. 81-86 6 p. |
artikel |
4 |
Challenges in collecting, accessing and evaluating post market surveillance AERS in patients receiving dietary supplements
|
Kingston, Rick |
|
2005 |
117 |
1-2 |
p. 137-144 8 p. |
artikel |
5 |
Clinical implications for patients on antithrombotic therapy while taking supplements
|
Ortel, Thomas L. |
|
2005 |
117 |
1-2 |
p. 75-80 6 p. |
artikel |
6 |
Comments on public health concerns: Facts, fiction, and gaps in knowledge
|
Hoffman, Freddie Ann |
|
2005 |
117 |
1-2 |
p. 177-178 2 p. |
artikel |
7 |
Conference summary and recommendations for research
|
Hasan, Ahmed A.K. |
|
2005 |
117 |
1-2 |
p. 229-230 2 p. |
artikel |
8 |
Current public health concerns about the use of dietary supplements: Facts, fiction and gaps in knowledge—An industry perspective on the development of heterogeneous natural ingredients as foods and drugs
|
Hoffman, Freddie Ann |
|
2005 |
117 |
1-2 |
p. 178-184 7 p. |
artikel |
9 |
Dialogue with patient care organizations
|
Costello, Rebecca |
|
2005 |
117 |
1-2 |
p. 211-225 15 p. |
artikel |
10 |
Dilemmas in herbal medicine: The clinician's viewpoint
|
Lee, Alison |
|
2005 |
117 |
1-2 |
p. 103-111 9 p. |
artikel |
11 |
Editorial Board
|
|
|
2005 |
117 |
1-2 |
p. CO3- 1 p. |
artikel |
12 |
Effect of dietary supplements on hemostasis: A case of bleeding in context of research and surveillance
|
Palmer, Mary E. |
|
2005 |
117 |
1-2 |
p. 33-38 6 p. |
artikel |
13 |
Effects of dietary supplements on aspirin and other antiplatelet agents: An evidence-based approach
|
Desai, Ditina |
|
2005 |
117 |
1-2 |
p. 87-101 15 p. |
artikel |
14 |
Effects of dietary supplements on coagulation and platelet function
|
Basila, Daniel |
|
2005 |
117 |
1-2 |
p. 49-53 5 p. |
artikel |
15 |
Effects of dietary supplements on hemostasis
|
Ansell, J. |
|
2005 |
117 |
1-2 |
p. 45-47 3 p. |
artikel |
16 |
FDA perspectives on supplement use by patients on antithrombotic therapy
|
Kim, Myong-Jin |
|
2005 |
117 |
1-2 |
p. 197-200 4 p. |
artikel |
17 |
FDA perspectives on supplement use by patients on antithrombotic therapy: Dietary supplement regulatory overview
|
Woo, Jason J.Y. |
|
2005 |
117 |
1-2 |
p. 193-196 4 p. |
artikel |
18 |
Novel mechanisms of aspirin pharmacologic actions: A model for studying herbal natural products
|
Wu, Kenneth K. |
|
2005 |
117 |
1-2 |
p. 61-64 4 p. |
artikel |
19 |
Opinions and research priorities
|
Bussey, Henry I. |
|
2005 |
117 |
1-2 |
p. 155-174 20 p. |
artikel |
20 |
Overview of hemostasis and thrombosis; current status of antithrombotic therapies
|
Horne, McDonald |
|
2005 |
117 |
1-2 |
p. 15-17 3 p. |
artikel |
21 |
Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements
|
Gage, Brian F. |
|
2005 |
117 |
1-2 |
p. 55-59 5 p. |
artikel |
22 |
Preface
|
|
|
2005 |
117 |
1-2 |
p. 1-3 3 p. |
artikel |
23 |
Pregnane X receptor: Predicting and preventing drug interactions
|
Kliewer, Steven A. |
|
2005 |
117 |
1-2 |
p. 133-136 4 p. |
artikel |
24 |
Remarks concerning new tools and methodologies for research and clinical practice
|
Kingston, Rick |
|
2005 |
117 |
1-2 |
p. 119-121 3 p. |
artikel |
25 |
Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy
|
Lichtenstein, Alice H. |
|
2005 |
117 |
1-2 |
p. 71-73 3 p. |
artikel |
26 |
Session I: Comments and discussion
|
|
|
2005 |
117 |
1-2 |
p. 39-42 4 p. |
artikel |
27 |
Session II: Comments and discussion
|
|
|
2005 |
117 |
1-2 |
p. 65-67 3 p. |
artikel |
28 |
Session III: Comments and discussion
|
|
|
2005 |
117 |
1-2 |
p. 113-115 3 p. |
artikel |
29 |
Session VI: Comments and discussion
|
|
|
2005 |
117 |
1-2 |
p. 201-207 7 p. |
artikel |
30 |
Synergism, antagonism, or additivity of dietary supplements: Application of theory to case studies
|
Borgert, Christopher J. |
|
2005 |
117 |
1-2 |
p. 123-132 10 p. |
artikel |
31 |
The interaction of dietary supplements with antithrombotic agents: Scope of the problem
|
Marder, Victor J. |
|
2005 |
117 |
1-2 |
p. 7-13 7 p. |
artikel |
32 |
The interference of botanicals and nutraceuticals with the effects of antithrombotic agents: How should the available evidence be weighed?
|
De Smet, Peter A.G.M. |
|
2005 |
117 |
1-2 |
p. 19-24 6 p. |
artikel |
33 |
Vitamins and minerals that affect hemostasis and antithrombotic therapies
|
Rebecca Couris, R. |
|
2005 |
117 |
1-2 |
p. 25-31 7 p. |
artikel |